Table 2 Perioperative data of all 11 patients
Variables | Data |
|---|---|
Postoperative hospital stays [median, (IQR)], d | 5 (5, 5) |
Estimated blood lose [median, (IQR)], ml | 20 (10, 30) |
Transfusion, n (%) | 0 (0%) |
Total operation time [median, (IQR)], min | 133 (84, 150) |
NOSES time [median, (IQR)], min | 15 (13, 16) |
Specimen size [median, (IQR)], cm | 6 (4.5, 13) |
VAS score [median, (IQR)] | |
24 h | 3 (2, 4) |
48 h | 1 (0, 1) |
Final pathologic stage | |
Clear cell carcinoma, n (%) | 9 (81.82%) |
Chromophobe cell carcinoma, n (%) | 1 (9.09%) |
Renal angiomyolipoma, n (%) | 1 (9.09%) |
T1a | 5 (45.45%) |
T1b | 5 (45.45%) |
T2 | 0 (0%) |
T3 | 1 (9.09%) |
T4 | 0 (0%) |
Pathologic stage | |
N0 | 0 (0%) |
N1 | 0 (0%) |
N2 | 0 (0%) |
N3 | 0 (0%) |